Introducing the flexible and modular RespiBio® real-time PCR assay menu for respiratory virus testing. The menu offering allows for the simultaneous testing of SARS-CoV-2, Flu A/B & RSV in one simple and easy to use test. The assays are freeze dried and ready to use with in built internal controls.
Qualitative detection, up to 96 RT-PCR per run
– SARS-CoV-2
Qualitative detection, up to 96 RT-PCR per run
– Flu A/B
– RSV
Qualitative detection, up to 48 RT-PCR per run
– SARS-CoV-2
– Flu A/B
– RSV
Clinical performance evaluation of the RespiBio® Panel 3 assay was carried out using 137 frozen archived specimens (nasopharyngeal swabs in viral transport medium) from patients with signs and symptoms of respiratory infection. The performance of the RespiBio® Panel 3 assay was compared to a commercial CE-IVD PCR assay targeting Influenza A, Influenza B, RSV and SARS-CoV-2 gene sequences.
e6/7 Cq value >40
Positive Percent Agreement: 100%
Negative Percent Agreement: 94.1%
aCq value >40; sample was originally reported as Influenza A
Positive Percent Agreement: 100%
Negative Percent Agreement: 99.1%
e6/7 Cq value >40
Positive Percent Agreement: 100%
Negative Percent Agreement: 98.1%
cCq value >35; d Cq value >40
Positive Percent Agreement: 94.1%
Negative Percent Agreement: 94.2%
